Loading asset research
Latigo Biotherapeutics Inc. Common Stock
LTGONasdaq · USD · StocksQuote as of · Exchange session not verified$22.12
+2.69%
Today
LTGO
Loading 1D prices…
Market cap
$1.5B
Volume
178.7K
52w high
$25.9352w low
$17.22Company profile
Latigo Biotherapeutics Inc. Common Stock
Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. The company's pipeline includes LTG-001, an oral NaV1.8 inhibitor designed to provide fast-acting, opioid-sparing relief for the treatment of acute pain; LTG-321, a NaV1.8 inhibitor candidate developed for the treatment of chronic musculoskeletal pain, starting with osteoarthritis; and LTG-418, a NaV1.8 inhibitor developed for the treatment of acute and chronic pain. Latigo Biotherapeutics, Inc. was formerly known as WVB-Desmond, Inc. and changed its name to Latigo Biotherapeutics, Inc. in March 2019. Latigo Biotherapeutics, Inc. was incorporated in 2018 and is based in Thousand Oaks, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Thousand Oaks, CA, United States
Employees
66
Fiscal year end
1231
CIK
2056611
Session & valuation
Open$21.76
Previous close$21.54
Day high$23.22
Day low$21.50
30-day avg. volume348.3K
Outstanding shares66.3M
Diluted EPS-$2.48
Latest annual period
P/E (trailing)-8.92
P/E (forward)-10.60
Price / book-0.08
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| AVLNAvalyn Pharma Inc. Common Stock | $1.5B | $0.00 | — | -$2.04 | -3.00% | Buy |
| PAHCPhibro Animal Health Corporation Class A Common Stock | $1.4B | $1.5B | +6.57% | $2.43 | -2.60% | Hold |
| INVAInnoviva Inc. Common Stock | $1.5B | $411.3M | +65.92% | $3.30 | +0.19% | Hold |
| LBRXLB Pharmaceuticals Inc Common Stock | $1.4B | $0.00 | — | -$3.13 | -3.50% | Buy |
| AAPGAscentage Pharma Group International American Depository Shares | $1.5B | — | — | -$13.96 | -3.42% | Buy |